Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases

Human Pathology

Volumn 36, Issue 10, 2005, Pages 1066-1073

  Saitou, Yukiko ^a   Shiraki, Katsuya ^a   Fuke, Hiroyuki ^a   Inoue, Tomoko ^a   Miyashita, Kazumi ^a   Yamanaka, Yutaka ^a   Yamaguchi, Yumi ^a   Yamamoto, Norihik ^a   Ito, Keiichi ^a   Sugimoto, Kazushi ^a   Nakano, Takeshi ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Apoptosis; HCV infection; Hepatitis; TNF related apoptosis inducing ligand; TRAIL; TRAIL receptor 1; TRAIL receptor 2; TRAIL R1 DR4; TRAIL R2 DR5

Indexed keywords

ADENOVIRUS VECTOR; ANTIBODY; BETA GALACTOSIDASE; DEATH RECEPTOR 5; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL STRAIN HEPG2; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; DRUG EFFECT; FLOW CYTOMETRY; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LYMPHOCYTIC INFILTRATION; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STAINING; UPREGULATION; VIRUS HEPATITIS;

ADENOVIRIDAE INFECTIONS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; FLOW CYTOMETRY; FLUORESCENT DYES; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLES; LIGANDS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 26644474569     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2005.07.019     Document Type: Article

References (37)

1. S.J. Zheng, P. Wang, and G. Tsabary Critical roles of TRAIL in hepatic cell death and hepatic inflammation J Clin Invest 113 2004 58 64
2. S. Nagata Apoptosis by death factor Cell 88 1997 355 365
3. K. Schulze-Osthoff, D. Ferrari, and M. Los Apoptosis signaling by death receptors Eur J Biochem 254 1998 439 459
4. S. Nagata, and P. Golstein The Fas death factor Science 267 1995 1449 1456
5. K. Shiraki, N. Tsuji, and T. Shioda Expression of Fas ligand in liver metastases of human colonic adenocarcinomas Proc Natl Acad Sci U S A 94 1997 6420 6425
6. K. Ando, K. Hiroishi, and T. Kaneko Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL J Immunol 1997 5283 5291
7. N. Hayashi, and E. Mita Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis J Viral Hepat 6 1997 357 365
8. T. Kondo, T. Suda, and H. Fukuyama Essential roles of the Fas ligand in the development of hepatitis Nat Med 3 1997 409 413
9. K. Ando, T. Moriyama, and L.G. Guidotti Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis J Exp Med 178 1993 1541 1554
10. R.M. Pitti, S.A. Marsters, and S. Ruppert Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family J Biol Chem 271 1996 12687 12690
11. S.R. Wiley, K. Schooley, and P.J. Smolak Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 673 682
12. H. Inoue, K. Shiraki, and T. Yamanaka Functional expression of tumor necrosis factor-related apoptosis-inducing ligand in human colonic adenocarcinoma cells Lab Invest 82 2002 1111 1119
13. J. Strater, H. Walczak, and T. Pukrop TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections Gastroenterology 122 2002 659 666
14. B. Mundt, F. Kuhnel, and L. Zender Involvement of TRAIL and its receptors in viral hepatitis FASEB J 17 2003 94 96
15. L.H. Han, W.S. Sun, and C.H. Ma Detection of soluble TRAIL in HBV infected patients and its clinical implications World J Gastroenterol 8 2002 1077 1080
16. L.M. Sedger, D.M. Shows, and R.A. Blanton IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression J Immunol 163 1999 920 926
17. J.J. Lum, A.A. Pilon, and J. Sanchez-Dardon Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l J Virol 75 2001 11128 11136
18. G.J. Gores, and S.H. Kaufmann Is TRAIL hepatotoxic? Hepatology 34 2001 3 6
19. H.L. Janssen, H. Higuchi, and A. Abdulkarim Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression J Hepatol 39 2003 414 420
20. R.G. Knodell, K.G. Ishak, and W.C. Black Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431 435
21. G. Pan, K. O'Rourke, and A.M. Chinnaiyan The receptor for the cytotoxic ligand TRAIL Science 276 1997 111 113
22. P. Schneider, M. Thome, and K. Burns TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB Immunity 7 1997 831 836
23. H. Walczak, M.A. Degli-Esposti, and R.S. Johnson TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL EMBO J 16 1997 5386 5397
24. G. Pan, J. Ni, and Y.F. Wei An antagonist decoy receptor and a death domain-containing receptor for TRAIL Science 277 1997 815 818
25. J.P. Sheridan, S.A. Marsters, and R.M. Pitti Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors Science 277 1997 818 821
26. M.A. Degli-Esposti, W.C. Dougall, and P.J. Smolak The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain Immunity 7 1997 813 820
27. T. Yamanaka, K. Shiraki, and K. Sugimoto Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines Hepatology 32 2000 482 490
28. Y. Yano, Y. Hayashi, and M. Nakaji Different apoptotic regulation of TRAIL-caspase pathway in HBV- and HCV-related hepatocellular carcinoma Int J Mol Med 11 2003 499 504
29. Z. Pei, L. Chu, and W. Zou An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice Hepatology 39 2004 1371 1381
30. X.P. Chen, S.Q. He, and H.P. Wang Expression of TNF-related apoptosis-inducing ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma World J Gastroenterol 9 2003 2433 2440
31. S. Armeanu, U.M. Lauer, and I. Smirnow Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes Cancer Res 63 2003 2369 2372
32. K. Sugimoto, K. Shiraki, and T. Ito Expression of functional CD40 in human hepatocellular carcinoma Hepatology 30 1999 920 926
33. M. Bennett, K. Macdonald, and S.W. Chan Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis Science 282 1998 290 293
34. S.J. Lee, Y.G. Kim, and K.W. Kang Effects of colchicine on liver functions of cirrhotic rats: beneficial effects result from stellate cell inactivation and inhibition of TGF beta1 expression Chem Biol Interact 147 2004 9 21
35. J.G. Wright, and J.W. Christman The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy Am J Respir Med 2 2003 211 219
36. T. Hanada, and A. Yoshimura Regulation of cytokine signaling and inflammation Cytokine Growth Factor Rev 13 2002 413 421
37. R. Donadelli, M. Abbate, and C. Zanchi Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation Am J Kidney Dis 36 2000 1226 1241